Background-Eradication ofThere was a significant diVerence (p < 0.001) in the proportion of patients in whom eradication was successful between LAC and LCM when compared with LAM, but no significant diVerence (p = 0.15) between LAM and OAM. Metronidazole resistance before treatment was identified as a significant prognostic factor with regard to eradication of H pylori. The regimens which contained metronidazole were significantly less eVective than those without metronidazole in the presence of pretreatment resistant H pylori. There was no diVerence among the treatment groups with regard to the incidence and severity of adverse events reported. Conclusions-All four treatment regimens were safe and eVective in eradicating H pylori in the patient population studied. LAC was the most eYcacious treatment in patients with pretreatment metronidazole resistant H pylori, and was significantly better than LAM and OAM in this group of patients. (Gut 1997; 41: 735-739)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.